Xylem Target Price

Where could XYL trade next? Consensus target price: $150.

Get informed when a big investor buys or sells

+ Follow

Share Price

$105.69

Average Target Price

$149.30

41.3% upside

10 analysts in the last 4 months

High: $165 | Low: $130

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-08-24	Jefferies	$150	41.9% upside
2026-08-13	UBS	$138	30.6% upside
2026-07-30	UBSJoshua Spector	$135	27.7% upside
2026-07-29	Mizuho Securities	$130	23% upside
2026-07-29	Stifel Nicolaus	$160	51.4% upside
2026-07-29	Robert W. BairdMichael Halloran	$165	56.1% upside
2026-07-29	Barclays	$159	50.4% upside
2026-07-20	Stifel Nicolaus	$157	48.5% upside
2026-07-16	RBC Capital	$159	50.4% upside
2026-06-25	JefferiesStephen Volkmann	$140	32.5% upside
2026-04-29	UBS	$133	25.8% upside
2026-04-29	OppenheimerBryan Blair	$158	49.5% upside
2026-04-29	Stifel Nicolaus	$159	50.4% upside
2026-04-29	Barclays	$154	45.7% upside
2026-04-21	UBS	$132	24.9% upside
2026-04-14	Stifel NicolausNathan Jones	$163	54.2% upside
2026-04-09	UBSJoshua Spector	$152	43.8% upside
2026-02-13	UBSJoshua Spector	$155	46.7% upside
2026-02-12	Oppenheimer	$165	56.1% upside
2026-02-11	Goldman Sachs	$158	49.5% upside
2026-02-11	Mizuho Securities	$138	30.6% upside
2026-02-11	Stifel Nicolaus	$175	65.6% upside
2026-02-11	Robert W. Baird	$161	52.3% upside
2026-01-07	BarclaysWilliam Grippin	$166	57.1% upside
2026-01-05	Mizuho SecuritiesBrett Linzey	$150	41.9% upside
2025-10-29	Stifel Nicolaus	$178	68.4% upside
2025-10-29	Argus Research	$170	60.8% upside
2025-10-29	Mizuho SecuritiesBrett Linzey	$160	51.4% upside
2025-10-29	RBC Capital	$176	66.5% upside
2025-10-29	Robert W. BairdMichael Halloran	$178	68.4% upside
2025-10-29	BarclaysWilliam Grippin	$172	62.7% upside
2025-09-18	Barclays	$165	56.1% upside
2025-08-05	UBS	$168	59% upside
2024-08-13	UBSDamian Karas	$165	56.1% upside
2024-07-31	Robert W. BairdMichael Halloran	$170	60.8% upside
2024-05-31	OppenheimerBryan Blair	$152	43.8% upside
2024-05-29	Argus ResearchJohn Eade	$165	56.1% upside
2024-05-03	Mizuho SecuritiesBrett Linzey	$135	27.7% upside
2024-05-03	RBC CapitalDeane Dray	$162	53.3% upside
2024-05-03	Robert W. BairdMichael Halloran	$155	46.7% upside
2024-04-08	Wolfe ResearchBrad Hewitt	$143	35.3% upside
2024-04-04	RBC CapitalDeane Dray	$153	44.8% upside
2023-08-18	Stifel NicolausNathan Jones	$133	25.8% upside
2023-02-08	Citigroup	$121	14.5% upside
2022-12-09	Citigroup	$123	16.4% upside
2022-11-16	Atlantic EquitiesRichard Radbourne	$129	22.1% upside
2021-11-22	Loop Capital MarketsScott Graham	$120	13.5% upside
2021-11-12	Argus ResearchJohn Eade	$150	41.9% upside
2021-08-04	CitigroupAndrew Kaplowitz	$131	23.9% upside
2021-05-05	Goldman SachsBrian K. Lee	$107	1.2% upside

Xylem (XYL) FAQ

Xylem (XYL) currently reports a target price of $150. Use the charts on this page to explore Xylem's target price history and peer comparisons.

Analysts' average 12-month price target for Xylem is $150, about 41.3% upside from the current share price of $105.69. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $150, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Xylem, and consider following XYL for alerts when major investors trade the stock.

Xylem is classified in the Industrials sector. On target price, it currently shows $150. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Industrials are usually more informative than comparing XYL with unrelated industries.